Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-06	Rachel Altshuler, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	4U01CA285013-03	Nicholas Hodges, Ph.D.
Kumar, Nagi B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Phase II Clinical trial of GTC in Men on Active Surveillance	5R01CA235032-06	Howard L. Parnes, M.D.
Labaer, Joshua	Arizona State University-Tempe Campus United States	High-throughput immunoproteomics for cancer biomarker discovery	5U2CCA271903-04	Christos Patriotis, Ph.D., M.Sc.
Labaer, Joshua	Arizona State University-Tempe Campus United States	Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck	5R33CA281802-03	Wendy Wang, Ph.D., M.Sc.
Lampe, Paul D.	Fred Hutchinson Cancer Center United States	Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer	5R01CA281801-03	Guillermo Marquez, Ph.D.
Langel, Stephanie N.	Case Western Reserve University United States	Antibody bound bacteria during HPV infection and cervical dysplasia	3R21CA289927-02S1	Goli Samimi, Ph.D., M.P.H.
Langevin, Anne-Marie R.	University Of Texas Hlth Science Center United States	Texas Pediatric NCORP	3UG1CA189855-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Leal, Ana Sofia Mendes	Indiana University Indianapolis United States	Nrf2, immune cells and lung cancer	7R01CA226690-06	Marjorie Perloff, M.D.
Lee, Juhun	University Of Pittsburgh At Pittsburgh United States	Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis	5R01CA269540-03	Sidney Fu, M.D.
Lee, Hakho	Massachusetts General Hospital United States	Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array	5U01CA284982-03	Nicholas Hodges, Ph.D.
Lee, Jeffrey Kuang Zou	Kaiser Foundation Research Institute United States	Vanguard Study Administrative Supplement	3UG1CA287011-02S1	Elyse LeeVan, M.D., M.P.H.
Lee, Richard T	Beckman Research Institute/City Of Hope United States	A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy	1R21CA260447-01A1	Rachel Altshuler, Ph.D.
Lehto, Rebecca H	Henry Ford Health + Michigan State University Health Sciences United States	Support for bereaved friend and family caregivers of cancer patients	1R03CA282943-01A1	Brennan Streck, Ph.D., RN, M.P.H.
Lenburg, Marc Elliott	Boston University Medical Campus United States	The Boston University - UCLA Lung Cancer Biomarker Characterization Center	5U2CCA271898-04	Guillermo Marquez, Ph.D.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants